Mosaic Trisomy 9 C2930908
A rare chromosomal abnormality where certain cells carry an extra chromosome 9. It can cause developmental delay, distinctive facial features, and multiple organ system involvement. Care is supportive and individualized to each person's needs.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Developmental delay
(neurological)Generalized symptoms
(congenital)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Growth restriction
(growth)Congenital heart defect
(cardiovascular)Skeletal abnormalities
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cardiac Assessment and Management
Comprehensive cardiac evaluation including echocardiogram to identify structural heart defects common in mosaic trisomy 9. Ongoing monitoring allows for timely surgical intervention when indicated, improving long-term outcomes.
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Early Intervention Developmental Therapy
Multidisciplinary developmental therapy including physical, occupational, and speech therapy tailored to the individual's abilities. Early intervention programs help maximize functional potential and address motor delays associated with the condition.
Additional treatment options
Seizure Management
Anticonvulsant therapy for seizure control when clinically indicated. Selection of appropriate antiepileptic medication depends on seizure type and individual patient factors.
medicationNutritional Support
Assessment and management of feeding difficulties common in mosaic trisomy 9. May include specialized feeding techniques, modified textures, or enteral nutrition support to ensure adequate caloric intake and growth.
dietaryGenetic Counseling Services
Family genetic counseling to discuss recurrence risks, prenatal testing options, and implications for family planning. Ongoing counseling provides support as patients age and face different life stages.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Mosaic Trisomy 9 C2930908?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Mosaic Trisomy 9 C2930908. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy